Provided by Tiger Fintech (Singapore) Pte. Ltd.

PAVmed

0.6551
-0.0549-7.73%
Post-market: 0.70070.0456+6.96%17:46 EDT
Volume:85.37K
Turnover:57.87K
Market Cap:11.20M
PE:1.32
High:0.7300
Open:0.7300
Low:0.6400
Close:0.7100
Loading ...

BRIEF-PAVmed Files Prospectus Relates To Potential Offer, Sale From Time To Time Of 3.3 Million Shares Of Common Stock By Selling Stockholders

Reuters
·
8 hours ago

PAVmed Files Prospectus Relates to Potential Offer, Sale From Time to Time of 3.3 Mln Shares of Common Stock by Selling Stockholders

THOMSON REUTERS
·
8 hours ago

PAVmed Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Yesterday

Lucid Diagnostics Closes Common Stock Offering

MT Newswires Live
·
11 Apr

Lucid Diagnostics Announces Closing of Public Offering of Common Stock

THOMSON REUTERS
·
11 Apr

BUZZ-U.S. STOCKS ON THE MOVE-Ford Motor, General Motors, AES

Reuters
·
10 Apr

BUZZ-Lucid Diagnostics tumbles on deep-discounted share sale

Reuters
·
10 Apr

BRIEF-Lucid Diagnostics Announces Pricing Of Public Offering Of Common Stock

Reuters
·
10 Apr

BUZZ-Lucid Diagnostics tumbles on stock offering unveil

Reuters
·
10 Apr

Lucid Diagnostics Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
10 Apr

Lucid Diagnostics Announces Proposed Public Offering of Common Stock

PR Newswire
·
10 Apr

BRIEF-Pavmed Inc Files For Offering Of 3.3 Million Shares Of Common Stock

Reuters
·
09 Apr

PAVmed files to sell 3.33M shares of common stock for holders

TIPRANKS
·
09 Apr

Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

PR Newswire
·
03 Apr

Pavmed’s Strategic Growth and Financial Challenges

TIPRANKS
·
29 Mar

Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology

PR Newswire
·
27 Mar

PAVmed Inc (PAVM) Q4 2024 Earnings Call Highlights: Strategic Growth and Financial Stability

GuruFocus.com
·
26 Mar

BRIEF-PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Reuters
·
25 Mar

PAVmed Inc: Qtrly EPS $0.12

THOMSON REUTERS
·
25 Mar

Lucid Diagnostics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
24 Mar